Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (441-450 of 1,211) with videos related to

Pageof 122
Sort By:
Congestive Heart Failure (Greenwich, Conn.)|August 4, 2007
Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarctionLisa M Mielniczuk, Gervasio A Lamas, Greg C Flaker, et al.
Journal of the American Heart Association|November 27, 2019
Association of Left Atrial Enlargement and Atrial Fibrillation With Cognitive Function and Decline: The ARIC-NCSMichael J Zhang, Faye L Norby, Pamela L Lutsey, et al.
JACC. Heart Failure|October 22, 2025
Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure With Reduced Ejection Fraction According to Age: The GALACTIC-HF TrialHenri Lu, Brian L Claggett, G Michael Felker, et al.
Journal of the American Heart Association|August 24, 2022
Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC StudyJenine E John, Brian Claggett, Hicham Skali, et al.
European Heart Journal|September 17, 2015
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionScott D Solomon, Brian Claggett, Eldrin F Lewis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 16, 2009
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study designHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
International Journal of Cardiology|July 10, 2026
Atrial myopathy subtypes: Association with and prediction of incident atrial fibrillation-The atherosclerosis risk in communities study (ARIC)Ethan D Moser, Ruoyu He, Wendy Wang, et al.
JACC. Heart Failure|September 13, 2020
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF AnalysisLuis E Rohde, Neal A Chatterjee, Muthiah Vaduganathan, et al.
JAMA|May 29, 2024
Revisiting Race and the Benefit of RAS Blockade in Heart Failure: A Meta-Analysis of Randomized Clinical TrialsLi Shen, Matthew M Y Lee, Pardeep S Jhund, et al.
European Heart Journal|February 15, 2011
Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunctionScott D Solomon, Sung Hee Shin, Amil Shah, et al.
Pageof 122

Showing results (441-450 of 1,211) with videos related to

Sort By:
Pageof 122
Congestive Heart Failure (Greenwich, Conn.)|August 4, 2007
Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarctionLisa M Mielniczuk, Gervasio A Lamas, Greg C Flaker, et al.
Journal of the American Heart Association|November 27, 2019
Association of Left Atrial Enlargement and Atrial Fibrillation With Cognitive Function and Decline: The ARIC-NCSMichael J Zhang, Faye L Norby, Pamela L Lutsey, et al.
JACC. Heart Failure|October 22, 2025
Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure With Reduced Ejection Fraction According to Age: The GALACTIC-HF TrialHenri Lu, Brian L Claggett, G Michael Felker, et al.
Journal of the American Heart Association|August 24, 2022
Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC StudyJenine E John, Brian Claggett, Hicham Skali, et al.
European Heart Journal|September 17, 2015
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionScott D Solomon, Brian Claggett, Eldrin F Lewis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 16, 2009
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study designHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
International Journal of Cardiology|July 10, 2026
Atrial myopathy subtypes: Association with and prediction of incident atrial fibrillation-The atherosclerosis risk in communities study (ARIC)Ethan D Moser, Ruoyu He, Wendy Wang, et al.
JACC. Heart Failure|September 13, 2020
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF AnalysisLuis E Rohde, Neal A Chatterjee, Muthiah Vaduganathan, et al.
JAMA|May 29, 2024
Revisiting Race and the Benefit of RAS Blockade in Heart Failure: A Meta-Analysis of Randomized Clinical TrialsLi Shen, Matthew M Y Lee, Pardeep S Jhund, et al.
European Heart Journal|February 15, 2011
Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunctionScott D Solomon, Sung Hee Shin, Amil Shah, et al.
Pageof 122